𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Androgen Action in Prostate Cancer

✍ Scribed by Sujit Basu; Donald J. Tindall

Book ID
107683252
Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
183 KB
Volume
1
Category
Article
ISSN
1868-8497

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Molecular regulation of androgen action
Molecular regulation of androgen action in prostate cancer
✍ Scott M. Dehm; Donald J. Tindall πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 178 KB

## Abstract Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action is exerted in target tissues via binding the and

Androgen receptor action in hormone-depe
Androgen receptor action in hormone-dependent and recurrent prostate cancer
✍ Irina U. Agoulnik; Nancy L. Weigel πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 177 KB

## Abstract The importance of androgens and androgen receptors (AR) in primary prostate cancer is well established. Metastatic disease is usually treated with some form of androgen ablation, which is effective for a limited amount of time. The role of AR in prostate cancers that recur despite andro

Defining the molecular action of HDAC in
Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer
✍ Mari BjΓΆrkman; Kristiina Iljin; Pasi Halonen; Henri Sara; Elisa Kaivanto; Matthi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 913 KB

## Abstract Gene fusions between prostate‐specific, androgen responsive __TMPRSS2__ gene and oncogenic ETS factors, such as __ERG__, occur in up to 50% of all prostate cancers. We recently defined a gene signature that was characteristic to prostate cancers with __ERG__ activation. This suggested e

The role of insulin-like growth factor b
The role of insulin-like growth factor binding protein-3 in the growth inhibitory actions of androgens in LNCaP human prostate cancer cells
✍ Lihong Peng; Jining Wang; Peter J. Malloy; David Feldman πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 489 KB πŸ‘ 2 views

## Abstract Insulin‐like growth factor binding protein‐3 (IGFBP‐3), an antiproliferative and proapoptotic protein, has been shown to be upregulated by growth inhibitory concentrations of androgens in LNCaP human prostate cancer (PCa) cells, but the mechanism of regulation and the role of IGFBP‐3 in